Longitudinal Changes in Insulin Resistance Indices During SGLT2 Inhibitor Therapy in Type 2 Diabetes: A Prospective Single-Arm Cohort Study
Preprints.org
Abstract
Sodium–glucose cotransporter-2 (SGLT2) inhibitors reduce cardiorenal events, but their association with insulin resistance in routine care is incompletely characterised, particularly where medication records cannot exclude exogenous insulin use.
The paper
Altıntaş A, Özer MT, Tepe Ö et al.
Preprints.org · 28 Aug 2026 · CC BY · Preprint, not peer-reviewed
